3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell CarcinomaFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorderRecruitingPhase 32026-03-17NCT05738694
The GUARDIAN Trial - Vasopressor Sub-StudyBlood PressureEnrolling by invitationPhase 42025-08-29NCT04934748
The GUARDIAN Trial - Induction Agent Sub-StudyMajor SurgeryEnrolling by invitationPhase 42025-08-29NCT04934683